isosorbide-5-mononitrate has been researched along with Atherogenesis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujimura, N; Hidaka, T; Higashi, Y; Kajikawa, M; Kihara, Y; Liao, JK; Maruhashi, T; Matsumoto, T; Nakashima, A; Noma, K | 1 |
Garaliene, V | 1 |
1 review(s) available for isosorbide-5-mononitrate and Atherogenesis
Article | Year |
---|---|
[Endothelium and nitric oxide].
Topics: Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Endothelium, Vascular; Homeostasis; Humans; Hypolipidemic Agents; Isosorbide Dinitrate; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Vasodilator Agents | 2008 |
1 trial(s) available for isosorbide-5-mononitrate and Atherogenesis
Article | Year |
---|---|
Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Atherosclerosis; Biomarkers; Female; Humans; Isosorbide Dinitrate; Leukocytes; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Prospective Studies; rho-Associated Kinases | 2015 |